Final Program

Go directly to a day's program:
Thursday | Friday | Saturday

All General Sessions to be held in the Salone delle Signorie Ballroom on the Lobby Level

1st Advances Against Aspergillosis Meeting for Patients will be held just prior to the scientific meeting on February 3, 2010. This half-day meeting (http://www.aspergillus.org.uk/AAA/) is unique as it will consist of clinicans lecturing on aspergillosis topics directly important for patients and families of patients. The lectures will be directed toward those patients and presented in an easily understandable format. Please see the link for information on the final program and registration for this meeting before the larger scientific meeting.

Wednesday, February 3
5:00 - 7:00 pm Early Registration
Foyer delle Signorie  Lobby Level

Thursday, February 4
7:00 - 9:00 am Registration
8:00 - 8:45 am Pre-program workshop: Alternative models for studying Aspergilli
Peter A. Warn, PhD
9:00 - 9:15 Opening ceremony
David A. Stevens, MD
Session 1: Interactions of Aspergillus With the Lung – New Insights
Moderators: Jean-Paul Latge, PhD & Antonio Cassone, PhD
9:15 - 9:40 Innate immunity defenses
Chad Steele, PhD
9:40 - 10:05 NADPH oxidase regulation of inflammation
Brahm H. Segal, MD
10:05 - 10:30 Aspergillus and response to hypoxia
Robert A. Cramer, Jr., PhD
10:30 - 10:55 Biofilms in the clinical setting
Frank-Michael Mueller, MD
10:55 - 11:25 Coffee / Tea Break
Piazzetta across from Salone delle Signorie Ballroom
Session 2: Antifungal Resistance
Moderators: David Perlin, PhD & Nir Osherov, PhD
11:25 - 11:50 Azole resistance in Aspergillus – is it a problem?
Susan J. Howard, PhD
11:50 am - 12:15 pm Susceptibility testing, breakpoints and molecular testing
Maiken Cavling Arendrup, MD, PhD
12:15 - 12:40 The unfolded protein stress response and resistance
David S. Askew, PhD
12:40 - 1:05 Intrinsically resistant species
Paul E. Verweij, MD, PhD
1:05 Lunch
Piazzetta across from Salone delle Signorie Ballroom
1:30 Workshop - Interesting clinical dilemmas
John E. Bennett, MD and Dimitrios P. Kontoyiannis, MD
Session 3: Incidence and Prevalence of Aspergillosis
Moderator: Maurizio Sanginetti, MD & Emilio Bouza, MD
2:30 - 2:55 Epidemiology and outcomes of aspergillosis in the 21st century: Strengths and weaknesses of surveillance databases
Dionissios Neofytos, MD
2:55 - 3:20 IA in developing countries
Arunaloke Chakrabarti, MD
3:20 - 3:55 ABPA in CF and asthma
Marianne Skov, MD
3:55 - 4:20 Rising tide of TB and chronic pulmonary aspergillosis
David W. Denning, MD
4:20 - 4:50 Coffee / Tea Break
Piazzetta across from Salone delle Signorie Ballroom
Session 4: Immunization and immunology of Aspergillosis
Moderators: Brahm Segal, MD & Luigina Romani, MD, PhD
4:50 - 5:15 Aspergillosis in leukaemia
Morena Caira, MD
5:15 - 5:40 Aspergillosis in transplant patients
Faouzi Saliba, MD
5:40 - 6:05 Candidate Aspergillus vaccines
David A. Stevens, MD
6:05 - 6:30 Adoptive T cell immunotherapy - into the clinic?
Thomas Lehrnbecher, MD, PhD
7:00 - 9:00 pm Welcome reception and poster session #1
Salone delle Signorie Ballroom and Foyer
Dinner Dinner - On your own

Friday, February 5, 2010 [back to top of page]
8:00 - 8:45 am Meet the Professor
  1. Naming Aspergillus species: evolving approaches to facilitate stability
    David L. Hawksworth, CBE
Session 5: New and Old Diagnostic Approaches
Moderators: John E. Bennett, MD & Paul E. Verweij, MD, PhD
9:00 - 9:25 Primary diagnostic approaches – molecular testing
Stephane Bretagne, MD
9:25 - 9:50 Galactomannan and response to therapy
Thomas F. Patterson, MD
9:50 - 10:15 Technetium scanning and aspergillosis
Antonella Lupetti, MD
10:15 - 10:40 Primary diagnostic approaches – breath volatiles
Stephen T. Chambers, PhD
10:40 - 11:10 Coffee / Tea Break
Piazzetta across from Salone delle Signorie Ballroom
Session 6: Risk Factors for IA
Moderators: Oliver Cornely, MD & Corrado Girmenia, MD
11:10 - 11:35 Clinical risk factors
John W. Baddley, MD
11:35 am - 12:00 pm TLRs as a risk factor
Pierre-Yves Bochud, MD
12:00 - 12:25 Innate immune defects as risk factors
Agostinto Carvalho, MD
12:25 - 12:50 Aspergillosis: Nosocomial or community acquired?
Philippe Vanhems, MD
Session 7: Lunch Seminar
Moderator: Katusuhiko Kamei, MD, PhD
12:50

Lunch
Piazzetta across from Salone delle Signorie Ballroom

Top six papers in aspergillosis in 2009/10
David Perlin, PhD & Claudio Viscoli, MD

2:00 pm Depart for Vatican Tour and Dinner

Saturday, February 6, 2010 [back to top of page]
8:00-8:45 am Meet the Professor

Syndromes caused by Aspergillus species and utility of immunodiagnostics
Kieren A, Marr, MD

Session 8: Aspergillosis in the Critically Ill
Moderators: William W. Hope, MD, PhD & Livio Pagano, MD
9:00 - 9:25 Clinical risk factors and diagnosis of IA in ICU
Elie Azoulay, MD
9:25 - 9:50 Severe asthma and Aspergillus
Ritesh Agarwal, MD
9:50 - 10:15 Monitoring immunoparesis in ICU
Guillaume Monneret, MD
10:15 - 10:40 Is combination therapy always justified for IA in ICU?
Raoul Herbrecht, MD
Mycoses Study Group Lecturer
10:40 - 11:10 Coffee / Tea Break
Piazzetta across from Salone delle Signorie Ballroom
Session 9: Aspergillus, Eosinophils and IgE – What Actually Goes On
Moderators: Richard B. Moss, MD & Arunaloke Chakrabarti, MD
11:10 - 11:35 Impact of Aspergillus proteases on allergic sensitization and the lung
David B. Corry, MD
11:35 am - 12:00 pm The Dectin-2/FcRgamma/Syk/cys-LT axis and allergy
Yoshihide Kanaoka, PhD
12:00 - 12:25 Monitoring Aspergillus allergic sensitization
Adriano Mari, MD
12:30 Lunch and poster session #2
Piazzetta and Salone delle Signorie Ballroom
Session 10: Surgical Infection and Outbreaks
Moderators: Cornelia Lass-Florl, PhD & Marianna Viviani, PhD
2:00 - 2:25 Aspergillus endocarditis
Joseph McCormack, MB, BCh
2:25 - 2:50 Outbreaks of aspergillosis
Malcolm Richardson, PhD
2:50 - 3:15 Outbreak investigation examples
S. Arun Balajee, PhD
Young Investigator Presentations (Selected by the Scientific Committee)
Moderator: Karl V. Clemons, PhD
3:15 - 3:25 #1
3:25 - 3:35 #2
3:35 - 3:45 #3
3:45 - 4:00 Discussion
4:00 - 4:30 Coffee / Tea Break
Piazzetta across from Salone delle Signorie Ballroom
Session 11: Newer Treatment Strategies
Moderators: Kieren A. Marr, MD & Claudio Viscoli, MD
4:30 - 4:55 Echinocandin or azole in non-neutropenic patients with IA
Emilio Bouza, MD
4:55 - 5:20 Voriconazole or Ambisome in neutropenia
Livio Pagano, MD
5:20 - 5:45 Role of azole level monitoring in management
Elaine M. Billaud, MD
5:45 - 6:10 Newer combination therapies
William J. Steinbach, MD
6:30 pm Farewell drinks
David W. Denning, MD

Discussion about the next AAA meeting

Dinner Dinner - On your own